📍Recalling firmDr. Reddy's Laboratories, Inc.107 College Rd E · Princeton, NJ 08540-6623
✎ GovInfoNow plain-language explainer
Dr. Reddy's Laboratories is recalling Mucus Relief D, Guaifenesin Pseudoephedrine HCl ER Tablets because the medication may be subpotent. This means the active ingredients might not provide the expected relief for congestion and mucus. The affected products were distributed nationwide by Walgreen Co. in 36-count blister packs. Read more at govinfonow.com/recall/35393-mucus-relief-d-recall-subpotent-drug-risk.
“Mucus Relief D Recall: Subpotent Drug Risk.” GovInfoNow, updated October 10, 2026. https://govinfonow.com/recall/35393-mucus-relief-d-recall-subpotent-drug-risk. Based on FDA recall #D-0388-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0388-2022%22&limit=1).
The FDA announced on Jan. 10, 2022, that Dr. Reddy's Laboratories Inc. voluntarily recalled Mucus Relief D tablets due to subpotent drug risks. Owners should contact the company for a refund, according to the FDA.
How to tell if you have it
Brand: Mucus Relief D
Product: Mucus Relief D Tablets
Strength: 600 mg/60mg
Packaging: 36-count blister pack in cartons
NDC: 0363-164-3
Lot codes: AT2102065A, AT2102065B
Expiration: 04/2023
Units affected: 18,336 cartons
The hazard
The recalled Mucus Relief D tablets are subpotent, meaning they may not contain the labeled amount of active ingredients, according to the FDA.
Context
GovInfoNow's records show Dr. Reddy's Laboratories Inc. has 85 other recalls on record since April 9, 2012. Other recent recalls of similar products include Dr. Reddy's Varenicline Tablets Recall (Nov. 11, 2025), Dr. Reddy's Succinylcholine Chloride Injection Recall (Sept. 26, 2025), and Dr. Reddy's Omeprazole Capsules Recall (June 30, 2025).
How to tell if you have this one
Look for Mucus Relief D, Guaifenesin Pseudoephedrine HCl ER Tablets (600 mg/60mg) in 36-count blister packs. Check the carton for NDC 0363-164-3 and Lot numbers AT2102065A or AT2102065B with an expiration date of 04/2023.
Brand
Mucus Relief D
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check your medication
Verify if your Mucus Relief D tablets match the recalled lot numbers (AT2102065A/B) and expiration date (04/2023).
Consult a pharmacist
Contact your pharmacist or healthcare provider for advice on what to do if you have the recalled product, as no specific remedy is listed in the record.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.2 years after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0388-2022 (January 10, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0388-2022 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.